Download AgendaRegister Now

Special Thanks to Our Supplier Partners

Executive Exchange and Dialogue for Small-to-Medium Life Science Enterprises, Fostering Mentorship, Collaboration and Driving Strategy for Sustainable Growth, High Level Corporate Management of Teams, Boards of Directors and Investors

Over the past 5 years, more than 450 Chief Executive Officers, Presidents and Founders from the life science industry have participated and engaged in the Q1 Life Science CEO Strategic Governance Forum, creating dialogue and synergy with like-minded executives rising to the challenge of a dynamic industry fueled by competitive growth, evolving regulatory and health policies and a changing population. Working with local industry leadership representing the most innovative and highly sought after organizations, Q1 has established a networking and discussion-based format which allows participants an opportunity to truly engage in the conversation, creating a problem solving and solution-based dialogue which has an immediate impact on corporate challenges.


  • Corporate lifecycle analysis, knowledge share and collaboration on:
    • Capital funding
    • Start-Up challenges
    • Licensing opportunities
    • Technology transfer
    • Corporate valuation
    • Mergers & acquisition
    • Exit strategies
  • Addressing the rising cost of conducting business in the life sciences
  • Regulatory challenges in securing FDA approval for new products
  • Evolving reimbursement frameworks & health policy considerations
  • Transformation of corporate narrative to gain investor buy-in
  • Leadership excellence and creating an effective corporate team
  • Leverage of partnerships & resources to advance product development
  • Industry specific tracks on pricing pressure & healthcare policy
  • Investor relations and executive board selection & management
  • Funding new entities: Dilutive and non-dilutive funding & capital
  • Convergence of technology & healthcare: Digital health revolution
  • Driving corporate growth through meeting unmet medical needs
  • Positioning organizations for sustainable future growth & development
  • Development of flexible corporate architecture to allow for rapid scaling
  • Economic role of drugs & devices in the spectrum of healthcare delivery


Aaron VandykeContact:

Aaron Van Dyke, Operations Director, Life Science
Q1 Productions
+1 (312) 840-9086